Andrew Warrilow

Andrew Warrilow


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2018 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
AWAndrew Warrilow
Andrew Warrilow
DMDuane Mellor
Duane Mellor
Andrew McKuneAndrew McKune
Andrew McKune
KPKate Pumpa
Kate Pumpa

14 February 2022 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
AWAndrew Warrilow
Andrew Warrilow
MTMurray R. Turner
Murray R. Turner
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
SSShawn Somerset
Shawn Somerset
The aim of this review was to examine: (1) the ability of cholecystokinin (CCK) or analogues of CCK to influence satiation and changes in body weight generally and (2) the efficacy of CCK in influencing satiation and eating behaviour specifically at physiological levels of dosing. A systematic review of the literature was performed following the PRISMA 2020 guidelines in five electronic databases investigating the effect of exogenous CCK or analogues on satiation and body weight. A meta-analysis of studies that infused CCK and measured satiation via changes in food/energy intake was also conducted. A total of 1054 studies were found using the search terms which were reduced to fifteen studies suitable for inclusion. Of the twelve studies measuring the effect on the weight of food ingested or energy intake, eleven showed a decrease. An analogue of CCK which can be administered orally failed to produce any weight loss at 24 weeks. The meta-analysis found the effect of CCK on satiation dosed at physiological levels was significant with a standardised mean difference of 0·57 (95 % CI 0·30, 0·85, P < 0·0001). By comparison, CCK dosed at higher, pharmacological levels also had a significant effect with a standardised mean difference of 0·91 (95 % CI 0·46, 1·36, P < 0·0001). Eight of the ten studies in the meta-analysis combined CCK infusion with some means to facilitate stomach distension. The present review found evidence that at both physiological and pharmacological levels of dosing CCK has a significant effect on satiation but no evidence for weight loss over the long term.

30 June 2020 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
AWAndrew Warrilow
Andrew Warrilow
SSShawn Somerset
Shawn Somerset
KPKate Pumpa
Kate Pumpa
RFRobert Fleet
Robert Fleet

14 February 2023 in Diabetology
Verified
Journal Article
Open access
PDF file
AWAndrew Warrilow
Andrew Warrilow
KPKate Pumpa
Kate Pumpa
SSShawn Somerset
Shawn Somerset
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
Obesity is one of the most important factors responsible for the marked increase in both the incidence and prevalence of type 2 diabetes mellitus (T2DM) in recent decades. Addressing the lifestyle factors associated with the progression to T2DM would present a potential rational early prevention strategy. The current evidence suggests that excessive energy intake is mediated via dietary fat. Biochemical signals released in response to the ingestion of food require supportive signalling from the presence of food in the stomach. The degree of supportive volume signalling emanating from the stomach influences both the satiation and satiety phases. The Lipids and Volume in Satiation and Satiety (LIVES) Hypothesis proposes that the biological feedback from fat intake appears to be influenced by the other macronutrients with which it is consumed. By identifying the various possible macronutrient combinations with fat, it is possible to construct a matrix of food composition/volume scenarios, which may help elucidate dysfunction in the human food energy regulation system within the context of the modern food environment.